United Therapeutics (UTHR) PEG Ratio: History & Chart

United Therapeutics Corporation (UTHR)UTHRUnited Therapeutics Corporation

About United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for individuals suffering from chronic and severe, often life-threatening, illnesses. Its operations span both the United States and international markets. The company's current commercial portfolio features several key therapeutics: Remodulin, prescribed for pulmonary arterial hypertension (PAH) to lessen symptoms experienced during physical activity. Tyvaso, an inhaled form of the prostacyclin analogue treprostinil, designed to enhance exercise capacity in patients with PAH and pulmonary hypertension linked to interstitial lung disease (PH-ILD). Orenitram, a treprostinil tablet formulation, also aims to boost the exercise capabilities of PAH patients. Unituxin, a monoclonal antibody utilized in the treatment of high-risk neuroblastoma. Adcirca, an oral PDE-5 inhibitor, which helps improve exercise performance in those with PAH. United Therapeutics also maintains a robust development pipeline, including: Tyvaso DPI, a dry powder inhaler version of Tyvaso. The Remunity Pump, a compact, lightweight, and durable infusion system for treprostinil, accompanied by a separate controller. RemoPro and Ralinepag, both investigational treatments for PAH. Aurora-GT, a gene therapy product focused on regenerating blood vessels within the lungs. Clinical trials such as Tyvaso PERFECT and TETON, which are evaluating Tyvaso's efficacy in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). The company has forged strategic alliances and licensing agreements with various entities, such as DEKA Research & Development Corp. for a semi-disposable subcutaneous treprostinil delivery system; MannKind Corporation for the development and licensing of treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. for the development of Ralinepag. Established in 1996, United Therapeutics Corporation is headquartered in Silver Spring, Maryland.

Silver Spring, MD

1,400 employees

www.unither.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Martine A. Rothblatt

View full financials

UTHR PEG Ratio Metrics

PEG RATIO

1.16

PEG RATIO AVG TTM

0.84

PEG RATIO AVG 3Y

0.59

PEG RATIO AVG 5Y

0.59

PEG RATIO AVG 10Y

0.44

PEG RATIO AVG 15Y

0.27

PEG RATIO AVG 20Y

0.24

CURRENT VS TTM AVG

+38.10%

CURRENT VS 3Y AVG

+97.45%

CURRENT VS 5Y AVG

+97.45%

CURRENT VS 10Y AVG

+161.41%

CURRENT VS 15Y AVG

+334.01%

CURRENT VS 20Y AVG

+381.79%

SECTOR MEDIAN · HEALTHCARE

1.82

median of 49 covered companies

CURRENT VS SECTOR MEDIAN

-36.26%

vs the sector median at left

NAME	MARKET CAP	PEG RATIO	TTM	3Y	5Y
United Therapeutics Corporation (UTHR)	$22.10B	1.16	0.84	0.59	0.59
Moderna, Inc. (MRNA)vs ›	$22.24B	N/A	0.18	0.14	0.14
STERIS plc (STE)vs ›	$22.35B	1.03	0.80	0.61	0.61
BioNTech SE (BNTX)vs ›	$22.98B	N/A	0.23	0.12	0.12
Viatris Inc. (VTRS)vs ›	$20.46B	N/A	0.02	1.20	0.80
West Pharmaceutical Services, Inc. (WST)vs ›	$23.99B	33.99	33.99	32.78	16.88
Incyte Corporation (INCY)vs ›	$24.33B	0.74	0.00	0.16	0.24
Waters Corporation (WAT)vs ›	$24.64B	75.61	75.61	40.77	27.51
Labcorp Holdings Inc. (LH)vs ›	$25.52B	1.28	0.79	0.79	0.47
Quest Diagnostics Incorporated (DGX)vs ›	$25.88B	1.43	4.21	4.21	2.20

NAME

MARKET CAP

PEG RATIO

TTM

United Therapeutics Corporation (UTHR)

$22.10B

1.16

0.84

0.59

Moderna, Inc. (MRNA)vs ›

$22.24B

N/A

0.18

0.14

STERIS plc (STE)vs ›

$22.35B

1.03

0.80

0.61

BioNTech SE (BNTX)vs ›

$22.98B

N/A

0.23

0.12

Viatris Inc. (VTRS)vs ›

$20.46B

N/A

0.02

1.20

0.80

West Pharmaceutical Services, Inc. (WST)vs ›

$23.99B

33.99

32.78

16.88

Incyte Corporation (INCY)vs ›

$24.33B

0.74

0.00

0.16

0.24

Waters Corporation (WAT)vs ›

$24.64B

75.61

40.77

27.51

Labcorp Holdings Inc. (LH)vs ›

$25.52B

1.28

0.79

0.47

Quest Diagnostics Incorporated (DGX)vs ›

$25.88B

1.43

4.21

2.20

PEG Ratio FAQ

What is the PEG ratio for United Therapeutics Corporation (UTHR)?

The PEG ratio for UTHR stock is 1.16.

Is United Therapeutics Corporation's PEG ratio high or low?

The PEG ratio of 1.16 is 97% above its 3-year average of 0.59, near the high end of its 3-year range (0.33–1.16).

What is the TTM average PEG ratio for United Therapeutics Corporation (UTHR)?

The TTM average PEG ratio for UTHR stock is 0.84.

What is the 3Y average PEG ratio for United Therapeutics Corporation (UTHR)?

The 3Y average PEG ratio for UTHR stock is 0.59.

What is the 5Y average PEG ratio for United Therapeutics Corporation (UTHR)?

The 5Y average PEG ratio for UTHR stock is 0.59.

What is the 10Y average PEG ratio for United Therapeutics Corporation (UTHR)?

The 10Y average PEG ratio for UTHR stock is 0.44.

What is the 15Y average PEG ratio for United Therapeutics Corporation (UTHR)?

The 15Y average PEG ratio for UTHR stock is 0.27.

What is the 20Y average PEG ratio for United Therapeutics Corporation (UTHR)?

The 20Y average PEG ratio for UTHR stock is 0.24.

DATE	PEG RATIO
2025-12-31	1.16
2024-12-31	0.52
2023-12-31	0.33
2022-12-31	0.34
2019-12-31	0.31
2018-12-31	0.19
2016-12-31	0.59
2015-12-31	0.11
2014-12-31	0.18
2012-12-31	0.17
2011-12-31	0.12
2010-12-31	0.08
2008-12-31	0.11
2006-12-31	1.34
2005-12-31	0.08
2003-12-31	0.83
2002-12-31	0.39
2001-12-31	0.11

DATE

PEG RATIO

2025-12-31

1.16

2024-12-31

0.52

2023-12-31

0.33

2022-12-31

0.34

2019-12-31

0.31

2018-12-31

0.19

2016-12-31

0.59

2015-12-31

0.11

2014-12-31

0.18

2012-12-31

0.17

2011-12-31

0.12

2010-12-31

0.08

2008-12-31

0.11

2006-12-31

1.34

2005-12-31

0.08

2003-12-31

0.83

2002-12-31

0.39

2001-12-31

0.11

PEG Ratio: 1.16

UTHR PEG Ratio Chart

UTHR Average PEG Ratio Chart

UTHR Current vs Average PEG Ratio Chart

UTHR PEG Ratio Metrics

UTHR Competitors' PEG Ratio

Growth-Adjusted Valuation

PEG Ratio Formula & Definition

PEG Ratio FAQ

UTHR PEG Ratio History

Related Metrics